Sebastian Bunk | Senior Director, Pipeline Research
Immatics Biotechnologies GmbH

Sebastian Bunk, Senior Director, Pipeline Research, Immatics Biotechnologies GmbH

Sebastian Bunk is a senior director at Immatics where he leads a team developing a pipeline of bispecific T cell-engaging receptor (TCER®) molecules. After joining Immatics in 2014, Sebastian focused on the establishment of innovative technologies for engineering of T-cell receptors and generation of bispecific TCER® molecules. He is an inventor on >20 patent families in the field of T cell receptor discovery and engineering as well as bispecific TCER®. He obtained his Ph.D. in Biochemical Pharmacology from the University of Konstanz. From 2009 to 2014 he worked in the biotherapeutics division at Baxter Innovations GmbH in Vienna.

Appearances:



Festival of Biologics Day 1 @ 17:50

Targeting of tumor-specific peptide antigens with bispecific T Cell-Engaging Receptor (TCER®) molecules

  • Update on Immatics’ T cell-engaging receptors (TCER®) pipeline
  • Development and preclinical validation of bispecific molecules equipped with soluble, high-affinity T cell receptors
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT

back to speakers